FindTrial
Sign In

Meloxicam periradicular injection in physiological solution vs physiological solution in the treatment of lumbar and/or sacral radiculite: single blind randomized study - Meloxicam09

Meloxicam periradicular injection in physiological solution vs physiological solution in the treatment of lumbar and/or sacral radiculite: single blind randomized study - Meloxicam09

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2009-016684-11-IT
Enrollment
Unknown
Registered
2010-08-20
Start date
2010-02-24
Completion date
Unknown
Last updated
2014-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with radiculite lumbar and/or sacral pain. MedDRA version: 9.1 Level: SOC Classification code 10029205

Interventions

Pharmaceutical Form: Solution for injection INN or Proposed INN: Meloxicam Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration number: 10- Pharmaceutical form of

Sponsors

ISTITUTI ORTOPEDICI RIZZOLI
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: major patients with acute or chronic lumbar pain and mono/bilateral sciatic without allergy to meloxicam Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: No collaborative patients, underage patients, patients with allergy to meloxicam and regional anaesthesia contraindications

Design outcomes

Primary

MeasureTime frame
Main Objective: Analgesic evaluation of meloxicam versus physiological solution;Secondary Objective: evaluation of disability;Primary end point(s): Analgesic evaluation of meloxicam versus physiological solution—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026